Physician profile
Cindy Cheng
NPI 1114989613
$6,557.79
in general payments reported to CMS, 2019-2025
24 companies · $1,375 in 2025
The $1,375 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,322 · 2020: $548 · 2021: $795 · 2022: $172 · 2023: $591 · 2024: $755 · 2025: $1,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,720.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,597.52 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $1,347.40 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Pfizer INC. | $460.28 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $424.58 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $414.81 | 2023-2025 | Caplyta |
| Abbvie INC. | $344.28 | 2019-2024 | Vraylar |
| Teva Pharmaceuticals USA, INC. | $259.03 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $234.31 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $229.38 | 2019 | |
| Allergan, INC. | $219.41 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.20 | 2019-2020 | |
| Novo Nordisk INC | $146.59 | 2019 | |
| Merck Sharp & Dohme LLC | $124.81 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $122.69 | 2021 | |
| Amgen INC. | $103.63 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $71.71 | 2019 | |
| Sanofi Pasteur INC. | $69.18 | 2020-2024 | |
| Circassia INC. | $34.86 | 2019 | |
| Scilex Pharmaceuticals INC. | $32.96 | 2019 | |
| Avion Pharmaceuticals | $29.34 | 2019-2020 | |
| Radius Health, INC. | $21.45 | 2019 | |
| Astellas Pharma US INC | $20.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $20.38 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $16.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.